Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Acro Biomedical (ACBM) Short-term Investments (2018 - 2023)

Acro Biomedical (ACBM) has 3 years of Short-term Investments data on record, last reported at $4230.0 in Q3 2023.

  • For Q3 2023, Short-term Investments changed N/A year-over-year to $4230.0; the TTM value through Sep 2023 reached $4230.0, changed N/A, while the annual FY2019 figure was $4992.0, N/A changed from the prior year.
  • Short-term Investments reached $4230.0 in Q3 2023 per ACBM's latest filing, roughly flat from $4230.0 in the prior quarter.
  • Across five years, Short-term Investments topped out at $4992.0 in Q1 2019 and bottomed at $4230.0 in Q1 2023.